The (cost-) effectivenes of a lifestyle intervention for male workers at risk for cardiovascular disease in the contruction industry in The Netherlands.
- Conditions
- Intervention group (receiving: see below) and control group, receiving usual care.
- Registration Number
- NL-OMON29087
- Lead Sponsor
- Stichting Arbouw
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 700
1. Gender: Male;
2. Age: 18-55 years;
3. Availability: Available for the study for the following 12 months;
4. Permission: Signed an informed consent form;
5. Health status: at risk for CVD, according to the screening instrument;
6. At risk for CVD according to the Framingham risk score, AND one or more of the following other risk factors:
Insufficiently active;
Fulfilling none of the Dutch PA standards (NNGB and Fitnorm);
Alcohol use;
No alcohol at all or > 35 glasses of alcohol per week;
HbA1c > 6.5%;
BMI >30 kg/m2;
Psychological complaints;
Tiredness or stress and/or treated for psychological disorders and/or low motivation to recover;
Heart complaints: shortness of breath and/or suffering from chest pain and/or diagnosed with or treated for CVD or its predictors (e.g. high blood pressure).
1. Unable to be physically active;
2. Not sufficiently capable of using the Dutch language;
3. Not having signed an informed consent form.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Dietary intake:<br>a. Fruits, vegetables and fish;<br>b. Sweet and salty snacks, soda, alcohol and sugar intake; <br>c. Slices of bread, plates for dinner; <br>2. Physical activity:<br>a. Fulfilling the NNGB and the Fitnorm; <br>b. Frequency, duration and intensity of habitual PA in leisure time; <br>3. Smoking status: Smoker/ non-smoker.
- Secondary Outcome Measures
Name Time Method 1. BMI (kg/ m²);<br>2. Systolic and diastolic blood pressure (mmHg);<br>3. HDL-cholesterol and total cholesterol (mmol/liter);<br>4. HbA1C (%);<br>5. Cardio respiratory fitness; <br>6. Stage of change; <br>7. Behaviour determinants;<br>8. Perceived general health; <br>9. Absenteeism;<br>10. Cost-effectiveness.